Medication Reviews in Elderly in Primary Care

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

369 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-09-01

Study Completion Date

2019-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is a follow-up of a randomized controlled study performed in 2011-2012 with medication reviews in elderly patients in Sweden. Additional data about mortality and hospital admissions have been collected.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Medication Reviews Bridging Healthcare: a Cluster-randomised Crossover Trial

NCT02999412

Medication Review

COMPLETED NA

An Intervention Study to Reduce Drug-related Problems and Readmissions Among Old People With Dementia

NCT01504672

Cognitive Impairment

COMPLETED NA

Educational Intervention to Reduce Drug-related Hospitalizations in Elderly Primary Health Care Patients

NCT01732302

Polypharmacy Adverse Drug Reaction

COMPLETED NA

The Interprofessional Medication Assessment for Older Patients

NCT02398812

Multimorbidity Polypharmacy

UNKNOWN NA

Development of a Coordinated, Community-Based Medication Management Model for Home-Dwelling Aged in Primary Care

NCT02545257

Drug Therapy, Combination Inappropriate Prescribing Polypharmacy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background Drug-related problems among the elderly population are common and increasing. Multi-professional medication reviews (MR) have arisen as a method to optimize drug therapy for frail elderly patients. Research has not yet been able to show conclusive evidence of the effect of MRs on mortality or hospital admissions. Aim The aim of this study was to assess the impact of MRs' on hospital admissions and mortality after six and 12 months in a frail population of 369 patients in primary care in a randomized controlled study. Methods Patients were blindly randomized to an intervention group (receiving MRs) and a control group (receiving usual care). Descriptive data on mortality and hospital admissions at six and 12 months were collected. Survival analysis was performed for time to death and time to the first hospital admission within 12 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drug Utilization Review

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients were blindly randomized to intervention or control group in 2011. This study is a follow-up with additional data collection for the included patient, a total of 369.

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Closed envelopes

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Patients in the intervention groups received multi-professional medication reviews. A nurse performed a symptom evaluation, a pharmacist assessed the drug list and made adjustment suggestions and finally a physician took action and performed medication changes.

Group Type EXPERIMENTAL